In this study we tested this hypothesis and found that the magnitude of circulating pan-cytokeratin+/CXCR4+ cells in patients with NSCLC was directly correlated with worse prognosis, and that these findings could be used as a foundation for future prospective biomarker studies. Here, CXCR4 is linked to non-small cell lung carcinoma.